Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

Related Articles by Review for PubMed (Select 20804804)

1.

Design of a robust infrastructure to monitor the safety of the pandemic A(H1N1) 2009 vaccination program in Taiwan.

Huang WT, Chen WW, Yang HW, Chen WC, Chao YN, Huang YW, Chuang JH, Kuo HS.

Vaccine. 2010 Oct 18;28(44):7161-6. doi: 10.1016/j.vaccine.2010.08.069. Epub 2010 Sep 15.

PMID:
20804804
2.

Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program.

Salmon DA, Akhtar A, Mergler MJ, Vannice KS, Izurieta H, Ball R, Lee GM, Vellozzi C, Garman P, Cunningham F, Gellin B, Koh H, Lurie N; H1N1 Working Group of Federal Immunization Safety Task Force.

Pediatrics. 2011 May;127 Suppl 1:S78-86. doi: 10.1542/peds.2010-1722L. Epub 2011 Apr 18. Review.

3.

Monitoring vaccine safety during an influenza pandemic.

Iskander J, Haber P, Herrera G.

Yale J Biol Med. 2005 Oct;78(5):265-75. Review.

4.

2009 pandemic influenza: a review.

Faruqui F, Mukundan D.

Curr Opin Pediatr. 2010 Aug;22(4):530-5. doi: 10.1097/MOP.0b013e32833bb81a. Review.

PMID:
20601883
5.

Pandemic influenza A H1N1 vaccines and narcolepsy: vaccine safety surveillance in action.

Barker CI, Snape MD.

Lancet Infect Dis. 2014 Mar;14(3):227-38. doi: 10.1016/S1473-3099(13)70238-X. Epub 2013 Dec 19. Review. Erratum in: Lancet Infect Dis. 2014 Oct;14(10):917.

PMID:
24360892
6.

Pandemic vaccines: promises and pitfalls.

Booy R, Brown LE, Grohmann GS, Macintyre CR.

Med J Aust. 2006 Nov 20;185(10 Suppl):S62-5. Review.

PMID:
17115955
7.

[Tetravaccine--new fundamental approach to prevention of influenza pandemic].

Onishchenko GG, Zverev VV, Katlinskiĭ AV, Semchenko AV, Korovkin SA, Mel'nikov SIa, Mironov AN.

Zh Mikrobiol Epidemiol Immunobiol. 2007 Jul-Aug;(4):15-9. Review. Russian.

PMID:
17882832
8.

[Review of the sudden death and death following immunization of influenza vaccine].

Li KL, Wu WD, Liu DW.

Zhongguo Yi Miao He Mian Yi. 2010 Jun;16(3):270-4. Review. Chinese.

PMID:
20726274
9.

[Research progress of influenza type A(H1N1) vaccine and monitoring adverse reaction].

Zhang WW, Li L, Zhu FC.

Zhongguo Yi Miao He Mian Yi. 2010 Jun;16(3):275-8. Review. Chinese.

PMID:
20726275
10.

[The new pandemic influenza A/H1N1. Antiviral agents for the initial stage--vaccine reduces the effects in the long run].

Uhnoo I, Bergquist C.

Lakartidningen. 2009 Jul 8-21;106(28-29):1814-9. Review. Swedish. No abstract available.

PMID:
19685621
11.

Features of the new pandemic influenza A/H1N1/2009 virus: virology, epidemiology, clinical and public health aspects.

Tang JW, Shetty N, Lam TT.

Curr Opin Pulm Med. 2010 May;16(3):235-41. doi: 10.1097/MCP.0b013e3283375727. Review.

PMID:
20375785
12.

Influenza a (H1N1) outbreak and challenges for pharmacotherapy.

Chawla R, Sharma RK, Bhardwaj JR.

Indian J Physiol Pharmacol. 2009 Apr-Jun;53(2):113-26. Review.

PMID:
20112815
13.

Assessing the safety of influenza immunization during pregnancy: the Vaccine Safety Datalink.

Kharbanda EO, Vazquez-Benitez G, Shi WX, Lipkind H, Naleway A, Molitor B, Kuckler L, Olsen A, Nordin JD.

Am J Obstet Gynecol. 2012 Sep;207(3 Suppl):S47-51. doi: 10.1016/j.ajog.2012.06.073. Epub 2012 Jul 9. Review.

PMID:
22920059
14.

Manufacturers' postmarketing safety surveillance of influenza vaccine exposure in pregnancy.

Khromava A, Cohen CJ, Mazur M, Kanesa-thasan N, Crucitti A, Seifert H.

Am J Obstet Gynecol. 2012 Sep;207(3 Suppl):S52-6. doi: 10.1016/j.ajog.2012.06.074. Epub 2012 Jul 9. Review.

PMID:
22920060
15.

Surveillance of adverse effects following vaccination and safety of immunization programs.

Waldman EA, Luhm KR, Monteiro SA, Freitas FR.

Rev Saude Publica. 2011 Feb;45(1):173-84. Review. English, Portuguese.

16.

The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety.

McNeil MM, Gee J, Weintraub ES, Belongia EA, Lee GM, Glanz JM, Nordin JD, Klein NP, Baxter R, Naleway AL, Jackson LA, Omer SB, Jacobsen SJ, DeStefano F.

Vaccine. 2014 Sep 22;32(42):5390-8. doi: 10.1016/j.vaccine.2014.07.073. Epub 2014 Aug 6. Review.

PMID:
25108215
17.

[National Campaign of Vaccination against the flu A (H1N1)v: National Follow-up of Pharmacovigilance].

Durrieu G, Caillet C, Lacroix I, Jacquet A, Faucher A, Ouaret S, Sommet A, Perault-Pochat MC, Kreft-Jaïs C, Castot A, Damase-Michel C, Montastruc JL; le réseau français des centres de pharmacovigilance.

Therapie. 2011 Nov-Dec;66(6):527-40. doi: 10.2515/therapie/2011075. Epub 2011 Dec 21. Review. French.

PMID:
22186078
18.

Ethics of vaccination programs.

Schwartz JL, Caplan AL.

Curr Opin Virol. 2011 Oct;1(4):263-7. doi: 10.1016/j.coviro.2011.05.009. Epub 2011 Jun 16. Review.

PMID:
22440783
19.

[H1N1 (continued), multiresistant Enterobacteriacea, new diagnostic tools].

Praz G.

Rev Med Suisse. 2011 Jan 12;7(277):36-40. Review. French.

PMID:
21309172
20.

Active surveillance for adverse events following immunization.

Crawford NW, Clothier H, Hodgson K, Selvaraj G, Easton ML, Buttery JP.

Expert Rev Vaccines. 2014 Feb;13(2):265-76. doi: 10.1586/14760584.2014.866895. Epub 2013 Dec 18. Review.

PMID:
24350637
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk